These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24187104)

  • 1. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
    Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
    J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
    Decker P; Olivier P; Risse J; Zuily S; Wahl D
    Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
    Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
    J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
    Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
    Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of tocilizumab in patients with Takayasu arteritis].
    Liao H; Pan LL; Du J; Gao N; Wang T
    Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):444-448. PubMed ID: 31159524
    [No Abstract]   [Full Text] [Related]  

  • 7. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
    Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
    Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature.
    Osman M; Emery D; Yacyshyn E
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1291-8. PubMed ID: 25869777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
    Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab in refractory aortitis: study on 16 patients and literature review.
    Loricera J; Blanco R; Castañeda S; Humbría A; Ortego-Centeno N; Narváez J; Mata C; Melchor S; Aurrecoechea E; Calvo-Alén J; Lluch P; Moll C; Mínguez M; Herrero-Beaumont G; Bravo B; Rubio E; Freire M; Peiró E; González-Vela C; Rueda-Gotor J; Pina T; Palmou-Fontana N; Calvo-Río V; Ortiz-Sanjuán F; González-Gay MÁ
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S79-89. PubMed ID: 24854377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
    Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
    Yoshifuji H
    Mod Rheumatol; 2019 Mar; 29(2):287-293. PubMed ID: 30427262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
    Loricera J; Blanco R; Hernández JL; Castañeda S; Humbría A; Ortego N; Bravo B; Freire M; Melchor S; Mínguez M; Salvatierra J; González-Vela C; Calvo-Río V; Santos-Gómez M; Pina T; González-Gay MA
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S44-53. PubMed ID: 27050507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 targeting in refractory Takayasu arteritis: serial noninvasive imaging is mandatory to monitor efficacy.
    Youngstein T; Mason JC
    J Rheumatol; 2013 Dec; 40(12):1941-4. PubMed ID: 24293617
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.
    Li H; Shuai Z
    Heart Vessels; 2022 May; 37(5):884-894. PubMed ID: 34750666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
    Bravo Mancheño B; Perin F; Guez Vázquez Del Rey Mdel M; García Sánchez A; Alcázar Romero PP
    Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for the treatment of patients with refractory Takayasu arteritis.
    Nakaoka Y; Higuchi K; Arita Y; Otsuki M; Yamamoto K; Hashimoto-Kataoka T; Yasui T; Ikeoka K; Ohtani T; Sakata Y; Shima Y; Kumanogoh A; Yamauchi-Takihara K; Tanaka T; Kishimoto T; Komuro I
    Int Heart J; 2013; 54(6):405-11. PubMed ID: 24309452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
    Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents.
    Sener S; Basaran O; Kaya Akca U; Atalay E; Kasap Cuceoglu M; Balik Z; Aliyev E; Bayindir Y; Batu ED; Hazirolan T; Bilginer Y; Ozen S
    Rheumatology (Oxford); 2022 Nov; 61(12):4885-4891. PubMed ID: 35262635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.